Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
US Physical TherapyUSPH +3.41%83 EV-to-EBIT is 22.89 as of Jul. 28, 2026, which is 1% below its 10-year median of 23.13. GuruFocus rates USPH with a GF Score™ of 83/100 and a GF Value™ of $108.32 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 471 Healthcare Providers & Services companies, US Physical Therapy ranks worse than 67.52% on this metric.
US Physical Therapy (NYSE:USPH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
US Physical Therapy's Enterprise Value for the quarter that ended in Mar. 2026 was $1,789.9 Mil.
US Physical Therapy's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $81.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
US Physical Therapy EV-to-EBIT Related Terms
US Physical Therapy EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for US Physical Therapy's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, US Physical Therapy's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
US Physical Therapy EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where US Physical Therapy's EV-to-EBIT falls into.
US Physical Therapy's current Enterprise Value is $1,854.4 Mil.
US Physical Therapy's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $81.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
US Physical Therapy (USPH) has a EV-to-EBIT of 22.89 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on US Physical Therapy and its competitors. This is near median its historical median of 23.13. Over the past decade, US Physical Therapy's EV-to-EBIT has ranged from 13.08 to 36.31. According to the industry distribution chart, US Physical Therapy ranks #318 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 67.5%.
Is US Physical Therapy's EV-to-EBIT too high?
US Physical Therapy's current EV-to-EBIT of 22.89 is near median its 10-year median of 23.13. Over the past 10 years, this metric has ranged from a low of 13.08 to a high of 36.31. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. US Physical Therapy's value of 22.89 is 44.2% above this industry median. Based on the distribution chart, US Physical Therapy ranks #318 out of 471 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, US Physical Therapy has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's EV-to-EBIT compare to NUTX and AMN?
According to the Healthcare Providers & Services industry distribution chart, US Physical Therapy ranks #318 out of 471 companies for EV-to-EBIT. This places US Physical Therapy in the lower half of its industry. The industry median EV-to-EBIT is 15.87. US Physical Therapy's value of 22.89 is 44.2% above this benchmark. Historically, US Physical Therapy's own EV-to-EBIT has ranged from 13.08 to 36.31 over the past decade. While the company's 10-year median is 23.13 vs. the industry median of 15.87, US Physical Therapy has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. US Physical Therapy's current EV-to-EBIT of 22.89 is 44.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on US Physical Therapy and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Physical Therapy's current EV-to-EBIT is 22.89, which is near median its own 10-year median of 23.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Modestly Undervalued. The stock's GF Value™ is $108.32, compared to a current price of $79.25 — trading 26.8% below its estimated fair value. The current EV-to-EBIT is 22.89, which is near median its 10-year median of 23.13 and 44.2% above the Healthcare Providers & Services industry median of 15.87. US Physical Therapy's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For US Physical Therapy (USPH), the current EV-to-EBIT is 22.89 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is US Physical Therapy (USPH) Overvalued in 2026?
Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued.
The current stock price of $79.25 is trading 26.8% below its estimated GF Value™ of $108.32.
GuruFocus considers US Physical Therapy to be Modestly Undervalued.
Key valuation signals for USPH:
EV-to-EBIT: 22.89 (near median its 10-year median of 23.13)
GF Value™: $108.32 vs. price of $79.25 (26.8% below fair value)
Industry Position: 44.2% above the Healthcare Providers & Services median (#318 of 471)
No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
83GF Score
Get the complete analysis for USPH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
USPH has been successfully added to your 
